Skip to content

Faraz Badar, MD

NPI 1669032652ActiveIndividual· Internal Medicine, Pulmonary Disease· Ocala, FL

Internal Medicine, Pulmonary Disease (MD) in Ocala, Florida, licensed in FL, with an NPI issued in June 2019. Part D covered 296 prescriptions written in 2024, 28% of them generic. Glaxosmithkline, LLC. was the largest of 8 companies reporting payments in 2025, $291.57 in all, mostly food and beverage.

Overview

NPI1669032652
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 20, 2019
Last updated in NPPESJun 10, 2026
Certified by providerJun 10, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001XME178175FL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pulmonary Disease (FL)

Part D prescriptions in 2024

Prescriptions (claims)296 · 360 30-day fills
Patients71
Total drug cost$87,433
Generic share28% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$291.57 · 10 payments from 8 companies
  • 2024$523.65 · 7 payments from 6 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$291.57 · 10 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pulmonologists in Ocala

All 19 pulmonologists in Ocala · All pulmonologists in Florida